ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$35.50
-1.07 (-2.93%)
âŧ
5d:
-1.74%
30d:
+2.84%
90d:
+1.05%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 24, 2026 at $36.33 · last confirmed Sep 30, 2026
Strength: 7.0/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ROIV is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ROIV is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $35.50, which is considered slightly low relative to its 30-day fair value range of $35.18 to $39.91.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $35.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $48.08 (+35.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is currently testing key support at $35.28. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $48.08 (+35.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$35.18 -
$39.91
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding ROIV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.4% below Wall St target ($48.08)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$35.18 -
$39.91
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$35.28
Resistance Level
$40.71
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.63
Wall Street Target
$48.08
(+35.4%)
Revenue Growth (YoY)
-33.5%
Earnings Growth (YoY)
-96.1%
Share & Embed Analysis
Last updated: October 01, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker
SELL
200000 shares
2026-04-20
Matthew Gline
SELL
289774 shares
2026-04-16
Jennifer Humes
SELL
13538 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 45 HOLD |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$851 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$139 | 66 BUY |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
